期刊文献+

呼吸机相关肺炎的病原菌临床分布及耐药监测 被引量:2

Microbiology of ventilator-associated pneumonia pathogens
下载PDF
导出
摘要 目的探讨呼吸机相关性肺炎(VAP)的病原菌分布及其耐药性,为临床抗感染药物的正确应用提供参考。方法对呼吸科监护病房使用呼吸机的32例患者进行目标性监测,对病原学检查和细菌对抗生素耐药性结果进行回顾性分析。结果32例病人检出98株致病菌,其中革兰阴性菌占69.39%(68/98),革兰阳性菌占21.43%(21/98),真菌占9.18%(9/98);革兰阴性菌中铜绿假单胞菌(32.65%),肺炎克雷伯菌(16.33%),鲍曼不动杆菌(9.19%)为主要致病菌;革兰阳性菌中金黄色葡萄球菌(14.29%)占主导地位;念珠菌属仍为真菌感染的主要致病菌;致病菌对常用抗菌药的耐药性普遍升高。结论VAP的病原菌以革兰阴性菌占优势,铜绿假单胞菌、肺炎克雷伯菌、金黄色葡萄球菌和鲍曼不动杆菌为RICU中VAP的主要致病菌,真菌感染的发生率不可忽视;致病菌耐药性升高,临床上应加强抗生素的合理使用。 Objective To examine the categories of ventilator- their drug- resistance so as to provide evidence for clinical rational use associated pneumonia (VAP) pathogens and of antibiotics. Methods 32 patients hospitalized in respiratory intensive care unit receiving ventilator respiration treatment were targetedly monitored. The microbial sensitivity tests and antibiotic test results were retrospectively analyzed. Results 98 pathogens were isolated from 32 patients, of which Gram - negative bacteria occupying 69.39% (68/69) of the isolates, Grampositive bacteria occupying 21.43% (21/98), and fungi occupying 9.18% (9/98). In Gram - negative bacteria isolates, Pseudomonas aeruginosa (32.65 % ) were the most commonly identified, followed by Klebsiella pneumoniae (16. 33% ) and Acinetobacter baumannii (9.19%) ; and in Gram - positive bacteria, Staphylococus aureus (14.29%) were the most commonly identified. Oidiomycetes tance of the pathogens were increasingly higher. were the major pathogens for fungi infections. The antibiotic resis- Conclusion In VAP pathogenic isolates, Gram- negative bacteria occupied the most. The most common VAP isolates in RICU were Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococus aureus and Acinetobacter baumannii, the incidence of fungi infection mignt not be ignored. The elevated elevatedantibiotic resistance of pathogens requied a rational clinical use of antibiotics.
出处 《右江民族医学院学报》 2008年第1期18-20,共3页 Journal of Youjiang Medical University for Nationalities
关键词 呼吸机相关性肺炎 病原 细菌 微生物敏感性试验 ventilator- associated pneumonia pathogen bacteria microbial sensitivity tests
  • 相关文献

参考文献5

二级参考文献26

  • 1陶一江,何礼贤.机械通气并发下呼吸道医院感染危险因素分析[J].中华医院感染学杂志,1996,6(4):193-196. 被引量:63
  • 2上海市医学会肺科学会肺部感染与肺间质性疾病学组.呼吸机相关肺炎[J].中华结核和呼吸杂志,1998,21:537-537.
  • 3[1]Bauer TT, Ferrer R, Angrill J, et al. Ventilator-associated pneumonia: incidence, risk factors, and microbiology[J]. Semin Respir Infect, 2000, 15(4): 272-279.
  • 4[2]Cook D. Ventilator associated pneumonia: perspectives on the burden of illness[J]. Intensive Care Med, 2000, 26 Suppl 1: S31-S37.
  • 5[3]Morehead RS, Pinto SJ. Ventilator-associated pneumonia[J]. Arch Intern Med, 2000, 160(13): 1926-1936.
  • 6[4]Kollef MH. Epidemiology and risk factors for nosocomial pneumonia[J]. Clin Chest Med, 1999, 20: 653-670.
  • 7[5]Mathews PJ, Mathews LM. Reducing the risks of ventilator-associated infections[J]. Dimens Crit Care Nurs, 2000, 19: 17-21.
  • 8[7]Daren KH, John WD, Shaun MD, et al. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial[J]. Crit Care Med, 2001, 29(8): 1495-1501.
  • 9[9]Finkelstein R, Rabino G, Kassis I, et al. Device-associated,device-day infection rates in an Israeli adult general intensive care unit[J]. J Hosp Infect, 2000, 44: 200-205.
  • 10[11]Torres A, Fàbregas N, Ewig S, et al. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references[J]. Crit Care Med, 2000, 28(8): 2799-2804.

共引文献2433

同被引文献25

  • 1刘庆华,何礼贤.呼吸机相关肺炎预防研究进展[J].国外医学(呼吸系统分册),2004,24(3):122-124. 被引量:25
  • 2Thongpiyapoom S, Narong MN, Suwalak N, et al. Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care unit in a university hospital in Thailand. J Med Assoc Thai, 2004,87 : 819-824.
  • 3Petdachai W. Ventilator-associated pneumonia in a newborn intensive care unit. Southeast Asian J Trop Med Public Health, 2004,35 : 724-729.
  • 4Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia a prospective cohort study. Indian J Crit Care Med,2005,9:211-216.
  • 5Arabi Y, Al-Shirawi N, Memish Z, et al. Ventilator-associated pneumonia in adults in developing countries: a systematic review. Int J Infect Dis,2008,12:505-512.
  • 6Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care, 2006,21 : 56-65.
  • 7Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically in patients. Ann Intern Med, 1998,129:433-440.
  • 8Pawar M, Mehta Y, Khurana P, et al. Ventilator-associated pneumonia : Incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth, 2003.17 : 22-28.
  • 9Teixeira PJ, Seligman R, Hertz FT, et al. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect,2007,65:361-367.
  • 10Jaimes F,De La Rosa G,Gomez E,et al. Incidence and risk factors for ventilator-associated pneumonia in a developing country:Where is the difference? Respir Med,2007,101:762-767.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部